Finance

Lists
Why is 603079 up 2.80%?
Dive Deeper
603079:SHA
Zhejiang Shengda Bio-pharm Co Ltd
CNÂ¥11.39
+2.80%
(+0.31) 1D
Nov 4, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603079...
Open
CNÂ¥11.08
High
CNÂ¥11.41
Low
CNÂ¥10.80
Mkt. cap
2.09B
Avg. vol.
3.51M
Volume
3.87M
Dividend
0.88%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 1, 2026
P/E ratio
62.16
52-wk high
CNÂ¥22.00
52-wk low
CNÂ¥9.94
EPS
CNÂ¥0.18
Shares outstanding
112.00M
No. of employees
1K
Open
CNÂ¥11.08
High
CNÂ¥11.41
Low
CNÂ¥10.80
Mkt. cap
2.09B
Avg. vol.
3.51M
Volume
3.87M
Dividend
0.88%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 1, 2026
P/E ratio
62.16
52-wk high
CNÂ¥22.00
52-wk low
CNÂ¥9.94
EPS
CNÂ¥0.18
Shares outstanding
112.00M
No. of employees
1K
News stories
From web sources and news partners
About Zhejiang Shengda Bio-pharm Co Ltd
CEO-
Employees1.08K
FoundedFeb 8, 1999
Headquarters-
SectorPharmaceutical industry
Industry-
Websitesd-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
223.25M
189.22M
199.84M
204.04M
Cost of goods sold
175.36M
136.99M
144.97M
152.28M
Cost of revenue
175.36M
136.99M
144.97M
152.28M
Research and development expenses
18.11M
10.09M
13.69M
9.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.59M
20.29M
21.99M
20.63M
Operating expense
48.77M
31.77M
39.22M
31.29M
Total operating expenses
224.13M
168.75M
184.19M
183.58M
Operating income
-879.22K
20.46M
15.65M
20.46M
Other non operating income
283.41K
-3.83M
3.63M
-10.53M
EBT including unusual items
8.03M
18.58M
13.30M
14.35M
EBT excluding unusual items
-279.90K
19.37M
13.02M
16.34M
Income tax expense
-2.51M
3.27M
4.09M
6.90M
Effective tax rate
-31.26%
17.59%
30.77%
48.07%
Other operating expenses
7.99M
1.54M
3.51M
543.59K
Net income
8.82M
13.17M
7.35M
4.59M
Net profit margin
3.95%
6.96%
3.68%
2.25%
Earnings per share
-
-
-
-
Interest and investment income
2.80M
2.86M
3.33M
2.05M
Interest expense
-45.11K
-115.42K
-1.93M
-3.30M
Net interest expenses
2.75M
2.74M
1.40M
-1.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.98M
39.32M
36.53M
39.32M
Gain or loss from assets sale
477.31K
-
563.49K
-563.49K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps